Primary endpoint is rise from floor (RFF) velocity with multiple secondary endpoints to assess muscle and pulmonary function - Javascript is required for you to be able to read premium content. Please ...

Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces that it is initiating a Phase 2b study of narmafotinib in pancreatic cancer exploring a new dosing regimen.

HBO's 'Bring Me The Beauties' uncovers new details of Eternal Values & its handsome, charismatic leader, who claimed to be an ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Is Philadelphia's largest office ...